Wenbin Jiang

Director, PRESIDENT AND CEO · 1 filing · Latest: May 18, 2026

Cytek Biosciences, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
CTKB	Wenbin Jiang	Director, PRESIDENT AND CEO	May 18, 2026	Tax Withholding	$3.55	25,542	$90.7K	5,477,203	May 20 5:50 PM
CTKB	Wenbin Jiang	Director, PRESIDENT AND CEO	May 18, 2026	Option Exercise	—	80,062	—	5,492,212	May 20 5:50 PM